Kodu・Aktsiate loetelu・Medpace Holdings Inc

Medpace Holdings Inc

Suletud

SektorTervishoid

599.66 1.64

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

587.22

Max

602.69

Põhinäitajad
By Trading Economics
Sissetulek	-2.5M 121M
Müük	727K 707M
P/E Sektori keskmine	33.683 68.51
Aktsiakasum	4.25
Kasumimarginaal	17.158
Töötajad	6,500
EBITDA	-21M 134M

Soovitused
By TipRanks
Soovitused	Neutraalne
12 kuu keskmine prognoos	-3.69% downside

Dividendid
By Acuity
Järgmine tulemuste avaldamine	21. okt 2026

Turustatistika
By TradingEconomics
Turukapital	924M 16B
Eelmine avamishind	598.02
Eelmine sulgemishind	599.66

Uudiste sentiment

By Acuity

50%

128 / 340 Pingereas Healthcare

Medpace Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

7. aug 2026, 19:16 UTC

Medpace Holdings Inc. shares are lower today, reflecting a slight pullback amid broader market factors, including economic signals and geopolitical tensions.

3. aug 2026, 19:26 UTC

Medpace Holdings Inc shares are higher, tracking broader market gains as major technology stocks boost investor confidence amid declining energy prices.

30. juuli 2026, 19:22 UTC

Medpace Holdings Inc is trading lower amid significant declines in the Life Sciences Tools & Services sub-sector, with unusual volatility noted during Thursday's session.

29. juuli 2026, 18:44 UTC

Macro Event

Medpace Holdings Inc. is trading higher, buoyed by the Federal Reserve's steady interest rates, despite broader market pressures from rising oil prices and geopolitical tensions.

28. juuli 2026, 23:11 UTC

Medpace Holdings Inc shares are higher in after-market hours, rebounding after four consecutive lower closes and remaining above the 20-day moving average.

27. juuli 2026, 16:56 UTC

News

Medpace Holdings Inc. shares are lower amid broader market volatility, despite reporting strong Q2 2026 business awards and raising guidance.

24. juuli 2026, 18:26 UTC

News

Analyst upgrades from RBC Capital and Truist Securities boost Medpace Holdings' price targets, contributing to modest gains during Friday's trading session.

22. juuli 2026, 23:22 UTC

Social Media

News

Medpace Holdings Inc. reported Q2 revenue of $707.3 million, exceeding expectations, and raised 2026 guidance, driving shares higher in after-market trading.

21. juuli 2026, 19:46 UTC

News

Medpace Holdings Inc. shares rise as analysts project 14.3% revenue growth ahead of Wednesday's Q2 earnings report, following a $706.6 million revenue last year.

Võrdlus sarnastega

Hinnamuutus

Medpace Holdings Inc Prognoos

Hinnasiht

By TipRanks

-3.69% langus

12 kuu keskmine prognoos

Keskmine 580.2 USD -3.69%

Kõrge 692 USD

Madal 450 USD

Põhineb 11 Wall Streeti analüütiku instrumendi Medpace Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

11 ratings

Osta

Hoia

Müü

Põhineb 11 analüütiku instrumendi Medpace Holdings Inc aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

128 / 340 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.